Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Leroy

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
Plos One|September 23, 2015
Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?Audrey Coilly, Jérôme Dumortier, Danielle Botta-Fridlund, et al.
Journal of Hepatology|March 23, 2024
Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC studyCatherine Lamarque, Lauriane Segaux, Philippe Bachellier, et al.
The Lancet. Gastroenterology & Hepatology|February 24, 2022
Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled studyAlexandre Louvet, Julien Labreuche, Christophe Moreno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2019
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized studyTarik Asselah, Stanislas Pol, Christophe Hezode, et al.
Journal of Infection and Public Health|April 1, 2020
Screening of hepatitis E in patients presenting for acute neurological disordersAude Belbézier, Alban Deroux, Françoise Sarrot-Reynauld, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trialMarc Bourlière, Pascaline Rabiega, Nathalie Ganne-Carrie, et al.
Journal of Clinical Gastroenterology|August 9, 2017
Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or RevisionArmand Garioud, Jean-François Cadranel, Arnaud Pauwels, et al.
Clinics and Research in Hepatology and Gastroenterology|June 30, 2020
Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohortAnais Vallet-Pichard, Jean-Michel Correas, Celine Dorival, et al.
European Journal of Clinical Pharmacology|August 7, 2019
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohortAurélie Barrail-Tran, Lauriane Goldwirt, Thibaut Gelé, et al.
Viruses|January 21, 2023
Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?Lucy Meunier, Mohamed Belkacemi, George Philippe Pageaux, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
Plos One|September 23, 2015
Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?Audrey Coilly, Jérôme Dumortier, Danielle Botta-Fridlund, et al.
Journal of Hepatology|March 23, 2024
Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC studyCatherine Lamarque, Lauriane Segaux, Philippe Bachellier, et al.
The Lancet. Gastroenterology & Hepatology|February 24, 2022
Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled studyAlexandre Louvet, Julien Labreuche, Christophe Moreno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2019
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized studyTarik Asselah, Stanislas Pol, Christophe Hezode, et al.
Journal of Infection and Public Health|April 1, 2020
Screening of hepatitis E in patients presenting for acute neurological disordersAude Belbézier, Alban Deroux, Françoise Sarrot-Reynauld, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trialMarc Bourlière, Pascaline Rabiega, Nathalie Ganne-Carrie, et al.
Journal of Clinical Gastroenterology|August 9, 2017
Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or RevisionArmand Garioud, Jean-François Cadranel, Arnaud Pauwels, et al.
Clinics and Research in Hepatology and Gastroenterology|June 30, 2020
Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohortAnais Vallet-Pichard, Jean-Michel Correas, Celine Dorival, et al.
European Journal of Clinical Pharmacology|August 7, 2019
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohortAurélie Barrail-Tran, Lauriane Goldwirt, Thibaut Gelé, et al.
Viruses|January 21, 2023
Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?Lucy Meunier, Mohamed Belkacemi, George Philippe Pageaux, et al.
Pageof 18